3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Follicular
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Lymphoma, Mantle-Cell
7
Recurrence
5
Lymphoma, B-Cell, Marginal Zone
5
Neoplasms
4
Lymphoma, B-Cell
4
Leukemia, B-Cell
3
Neoplasm, Residual
2
Burkitt Lymphoma
2
Mature B-Cell Malignancies
1
Lymphatic Diseases
1
Leukemia, Hairy Cell
1
Leukemia
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Cytokine Release Syndrome
1
Interventions
pembrolizumab
22
Nivolumab
14
enfortumab vedotin
13
Gemcitabine
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cisplatin
8
Carboplatin
8
sacituzumab govitecan
6
Docetaxel
6
avelumab
5
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
obinutuzumab
×
90 days
×
Clear all
No trials found.